Pregled Manuscript autora: "Padrón, José M."
Prikaz rezultata 1-3 od 3
-
CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells.
Dinić, Jelena; Ríos-Luci, Carla; Karpaviciene, Ieva; Cikotiene, Inga; Fernandes, Miguel X.; Pešić, Milica; Padrón, José M. (Investigational New DrugsInvestigational New Drugs, 2020) -
DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells
Podolski-Renić, Ana; Banković, Jasna; Dinić, Jelena; Ríos-Luci, Carla; Fernandes, Miguel X.; Ortega, Nuria; Kovačević-Grujičić, Nataša; Martín, Víctor S.; Padrón, José M.; Pešić, Milica (Amsterdam: Elsevier, 2017) -
Repurposing old drugs to fight multidrug resistant cancers
Dinić, Jelena; Efferth, Thomas; García-Sosa, Alfonso T.; Grahovac, Jelena; Padrón, José M.; Pajeva, Ilza; Rizzolio, Flavio; Saponara, Simona; Spengler, Gabriella; Tsakovska, Ivanka (Churchill Livingstone, 2020)